About Mayne Pharma International

Mayne Pharma International (Mayne Pharma) is a technology driven, oral drug delivery corporation that competes in the branded generic product and value added active pharmaceutical ingredient (API) market. Mayne Pharma specialises in general development and manufacture of a number of eminent super generic pharmaceuticals for out licensing and contract product development and manufacture.

With widespread expertise in the drug delivery systems field, integrating projects both nationally and internationally, Mayne Pharma is at the forefront of the global market for the development and manufacture of oral, modified-release and dermaceutical formulations.

The Mayne Pharma South Australian site has a well established manufacturing facility that is capable of developing products from formulation and clinical trial stage, to validation and registration, right through to commercial scale manufacture of packaged goods ready to be distributed. Additionally the site is GMP compliant as certified by chief regulatory authorities including the FDA (United States) and TGA (Australia) with mutual recognition from the MHRA (United Kingdom), TPD (Canada) and various Asian regulatory authorities.